Gregory Strunk
Family Medicine · Huntingdon, PANPI 1740486281
Payments from drug & device makers
Across 134 payments — averaging $17.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$401
- Lilly USA, LLC$340
- Sanofi-aventis U.S. LLC$291
- Teva Pharmaceuticals USA, Inc.$153
- Novartis$150
- GSK$134
- plus $875 from 18 others
What the payments were for
- Food & beverage$2,27897%
- Education$653%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 23 | $401 |
| Lilly USA, LLC | 16 | $340 |
| Sanofi-aventis U.S. LLC | 20 | $291 |
| Teva Pharmaceuticals USA, Inc. | 9 | $153 |
| Novartis | 7 | $150 |
| GSK | 7 | $134 |
| Paratek Pharmaceuticals, Inc. | 7 | $124 |
| Astellas Pharma US Inc | 6 | $121 |
| Kowa Pharmaceuticals America, Inc. | 8 | $110 |
| AbbVie | 5 | $95 |
| Pfizer | 4 | $63 |
| Biohaven Pharmaceuticals, Inc. | 3 | $59 |
| Genentech USA, Inc. | 4 | $55 |
| Sanofi Pasteur Inc. | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Merck | 2 | $31 |
| Boston Scientific | 1 | $29 |
| Exact Sciences | 1 | $20 |
| Averitas Pharma Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $14 |
| Corcept Therapeutics | 1 | $14 |
| Medtronic | 1 | $14 |
| Bayer | 1 | $13 |
How this compares
$2,343 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 43 | $47,277 |
| MounjaroTirzepatide | 33 | $36,547 |
| TrulicityDulaglutide | 31 | $34,225 |
| EliquisApixaban | 31 | $24,770 |
| JanuviaSitagliptin Phosphate | 16 | $22,219 |
| VraylarCariprazine Hcl | 12 | $22,097 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $21,789 |
| JardianceEmpagliflozin | 14 | $21,388 |
| RybelsusSemaglutide | 12 | $12,470 |
| FarxigaDapagliflozin Propanediol | 11 | $11,864 |
| XareltoRivaroxaban | 14 | $11,790 |
| MyrbetriqMirabegron | 14 | $11,053 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $8,848 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 17 | $8,460 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $7,876 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $340 | $70,77264 claims |
| Novo NordiskOzempic, Rybelsus | $401 | $59,74855 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $134 | $29,66543 claims |
| PfizerEliquis | $63 | $24,77031 claims |
| MerckJanuvia | $31 | $22,21916 claims |
| AbbVieVraylar | $95 | $22,09712 claims |
| Astellas Pharma US IncMyrbetriq | $121 | $11,05314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Huntingdon
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.